Literature DB >> 2158202

Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product.

D Figarella-Branger1, J F Pellissier, N Bianco, B Devictor, M Toga.   

Abstract

In ten patients with inclusion body myositis (IBM) five muscular biopsies showed profuse inflammatory exudates and three showed a few scattered inflammatory cells with partial invasion in some muscle fibers. No inflammatory cells were seen in two cases. In all patients, histopathological, histomorphometric and immunocytochemical studies were performed. Immunocytochemistry for the class I and class II major histocompatibility complex gene product (MHC) was performed in all cases and in ten control muscles including: normal muscles [3], dermatomyositis [3], polymyositis [3], scleroderma [1]. In the five cases of IBM with inflammatory exudates, subsets of lymphocytes were analyzed with a panel of monoclonal antibodies against B cells, T4 cells, T8 cells, K and natural killer cells and macrophages. Some muscle fibers expressed class I MHC antigens in the inflammatory cases of IBM. These fibers were near the inflammatory exudates and occasionally showed a partial invasion. No expression of class I MHC was found in normal muscles and in non-inflammatory cases of IBM. The antigen which triggers the mononuclear cells in the inflammatory forms of IBM is probably not the filamentous inclusions in rimmed vacuoles. In other inflammatory myopathies, expression of class I MHC was present on all fibers in polymyositis, only in the perifascicular area in dermatomyositis and in scleroderma. It could be suggested that the term "inclusion body muscle disease" be applied to cases with rimmed vacuoles and "IBM-like" filaments without inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158202     DOI: 10.1007/BF00296113

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  34 in total

1.  The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female.

Authors:  M H Brooke; W K Engel
Journal:  Neurology       Date:  1969-03       Impact factor: 9.910

2.  Regulation of histocompatibility antigens by interferon.

Authors:  F Rosa; D Hatat; A Abadie; M Fellous
Journal:  Ann Inst Pasteur Immunol (1985)       Date:  1985 Jan-Feb

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis.

Authors:  K Arahata; A G Engel
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

5.  Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells.

Authors:  K Arahata; A G Engel
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

6.  Intranuclear inclusions in oculopharyngeal dystrophy.

Authors:  T W Smith; D Chad
Journal:  Muscle Nerve       Date:  1984-05       Impact factor: 3.217

7.  Hereditary distal myopathy with filamentous inclusions.

Authors:  S Matsubara; H Tanabe
Journal:  Acta Neurol Scand       Date:  1982-04       Impact factor: 3.209

8.  The detailed distribution of HLA-A, B, C antigens in normal human organs.

Authors:  A S Daar; S V Fuggle; J W Fabre; A Ting; P J Morris
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

9.  Inclusion body myositis: a chronic persistent mumps myositis?

Authors:  S M Chou
Journal:  Hum Pathol       Date:  1986-08       Impact factor: 3.466

10.  Oculopharyngeal muscular dystrophy and distal myopathy. Intrafamilial difference in the onset and distribution of muscular involvement.

Authors:  N Fukuhara; T Kumamoto; T Tsubaki; T Mayuzumi; H Nitta
Journal:  Acta Neurol Scand       Date:  1982-05       Impact factor: 3.209

View more
  11 in total

Review 1.  Polymyositis/dermatomyositis: the current position.

Authors:  A Urbano-Márquez; J Casademont; J M Grau
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

2.  Intranuclear and cytoplasmic filamentous inclusions in distal myopathy (Welander).

Authors:  K Borg; F M Tomé; L Edström
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis.

Authors:  Kenneth C Parker; Sek Won Kong; Ronan J Walsh; Mohammad Salajegheh; Behzad Moghadaszadeh; Anthony A Amato; Remedios Nazareno; Yin Yin Lin; Bryan Krastins; David A Sarracino; Alan H Beggs; Jack L Pinkus; Steven A Greenberg
Journal:  Muscle Nerve       Date:  2009-06       Impact factor: 3.217

4.  Glucocorticoid-sensitive hereditary inclusion body myositis.

Authors:  M Naumann; H Reichmann; H H Goebel; C Moll; K V Toyka
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

5.  HLA associations with inclusion body myositis.

Authors:  M J Garlepp; B Laing; P J Zilko; W Ollier; F L Mastaglia
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

6.  A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli.

Authors:  K Nagaraju; N Raben; G Merritt; L Loeffler; K Kirk; P Plotz
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

7.  Expression of granulysin in polymyositis and inclusion-body myositis.

Authors:  K Ikezoe; S Ohshima; M Osoegawa; M Tanaka; K Ogawa; K Nagata; J-i Kira
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10       Impact factor: 10.154

8.  Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.

Authors:  P Englund; E Lindroos; I Nennesmo; L Klareskog; I E Lundberg
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

9.  Inclusion body myositis: clinical and histopathological features of 36 patients.

Authors:  S Beyenburg; S Zierz; F Jerusalem
Journal:  Clin Investig       Date:  1993-05

10.  Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture.

Authors:  J R Beauchamp; D J Abraham; G Bou-Gharios; T A Partridge; I Olsen
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.